Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel 1,2,4-triazole derivatives as apoptotic inducers targeting p53: Synthesis and antiproliferative activity
Hesham A. M. Gomaa, Hany A.M. El-Sherief, Shaimaa Hussein, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104369-104369
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Recent advances in the chemistry of 1,2,4-triazoles: Synthesis, reactivity and biological activities
Abderrahmen Abdelli, Safa Azzouni, Romain Plais, et al.
Tetrahedron Letters (2021) Vol. 86, pp. 153518-153518
Open Access | Times Cited: 78
Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors
Mohamed A. Mahmoud, Anber F. Mohammed, Ola I. A. Salem, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 10
Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis–Pyrazoline Derivatives as Dual EGFR/BRAFV600E Inhibitors
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Eman A. M. Beshr, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 9104-9104
Open Access | Times Cited: 15
Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies
Sakshi Priya, Md. Shafiqul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 4, pp. 449-465
Closed Access
A review on recent progress in triazole based chromogenic and fluorogenic chemosensor for the detection of Cu2+ metal ion
Umme Salma, Md. Zafer Alam, Suhail Ahmad, et al.
Inorganica Chimica Acta (2025), pp. 122600-122600
Closed Access
Design and synthesis of new triarylimidazole derivatives as dual inhibitors of BRAFV600E/p38α with potential antiproliferative activity
Bahaa G. M. Youssif, Ahmed M. Gouda, Amr H. Moustafa, et al.
Journal of Molecular Structure (2021) Vol. 1253, pp. 132218-132218
Closed Access | Times Cited: 38
Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
Lamya H. Al-Wahaibi, Yaser A. Mostafa, Mostafa Abdelrahman, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 22
p53 as a potential target for treatment of cancer: A perspective on recent advancements in small molecules with structural insights and SAR studies
Chahat, Rohit Bhatia, Bhupinder Kumar
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115020-115020
Closed Access | Times Cited: 22
Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4-b]indol-3-one Derivatives as Potent Inhibitors of EGFRT790M/BRAFV600E Pathways
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1269-1269
Open Access | Times Cited: 14
New Fluoroquinolone‐1,2,4‐triazoles as Potent Antibacterial Agents: Design, Synthesis, Docking Studies and in Silico ADME Profiles
Venkateswara Rao Gollapalli, Hari Babu Bollikolla, Tejeswara Rao Allaka, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 4
Closed Access | Times Cited: 14
Synthetic and Medicinal Perspective of 1,2,4‐Triazole as Anticancer Agents
Bhagyashri Rathod, Kapil Kumar
Chemistry & Biodiversity (2022) Vol. 19, Iss. 11
Closed Access | Times Cited: 21
Design, synthesis and evaluation of novel 1,2,4-triazole derivatives as promising anticancer agents
Leila Emami, Sara Sadeghian, Ayyub Mojaddami, et al.
BMC Chemistry (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 21
New Schiff bases derived from dimethylpyridine-1,2,4-triazole hybrid as cytotoxic agents targeting gastrointestinal cancers: Design, synthesis, biological evaluation and molecular docking studies
Małgorzata Strzelecka, Benita Wiatrak, Paulina Jawień, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106758-106758
Open Access | Times Cited: 10
Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy
Chahat, Nidhi Nainwal, Yogesh Murti, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3
Novel pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety: design, synthesis, molecular docking, and biological evaluation as potential multi-target cytotoxic agents
Ahmed M. Shawky, Nashwa A. Ibrahim, Ashraf N. Abdalla, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1312-1332
Open Access | Times Cited: 21
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties
Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 15
Prospects for the search for new biologically active compounds among the derivatives of the heterocyclic system of 1,2,4-triazole.
Sameliuk Yurii, А. Г. Каплаушенко, Natalia NEDOREZANIUK, et al.
Hacettepe University Journal of the Faculty of Pharmacy (2022)
Open Access | Times Cited: 14
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6586-6586
Open Access | Times Cited: 8
Thiazolotriazoles As Anti-infectives: Design, Synthesis, Biological Evaluation and In Silico Studies
Umadevi Kizhakke Purakkel, Ganji Praveena, Valli Y. Madabhushi, et al.
ACS Omega (2024) Vol. 9, Iss. 8, pp. 8846-8861
Open Access | Times Cited: 2
First Synthesis of the Novel Triazolo[3,4- b ][1,3,4]Thiadiazoles and Triazolo[3,4- b ][1,3,4]Thiadiazines Linked Chromeno[2,3- b ]Pyridine
Magdy A. Ibrahim, Sami A. Al‐Harbi, Esam S. Allehyani, et al.
Polycyclic aromatic compounds (2023) Vol. 44, Iss. 1, pp. 361-374
Closed Access | Times Cited: 6
Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action
Fatma A. Mohamed, Saleha Y. M. Alakilli, Eman Fawzy El Azab, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 4, pp. 734-744
Closed Access | Times Cited: 6
Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents
Lamya H. Al-Wahaibi, Anber F. Mohammed, Mostafa Abdelrahman, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 1039-1039
Open Access | Times Cited: 6
Development of novel 1,2,4-triazole containing compounds with anticancer and potent anti-CB1 activity
Sümbül Yıldırım, Aslıhan Ayvaz, Arif Mermer, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 8, pp. 3862-3873
Open Access | Times Cited: 6
Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl)quinolin-2(1H)-ones as Multi-Target Inhibitors
Essmat M. El‐Sheref, Stefan Bräse, Hendawy N. Tawfeek, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13300-13300
Open Access | Times Cited: 6
Design, synthesis, and modelling study of new 1,2,3‐triazole/chalcone hybrids with antiproliferative action as epidermal growth factor receptor inhibitors
Mohamed T.‐E. Maghraby, Ola I. A. Salem, Bahaa G. M. Youssif, et al.
Chemical Biology & Drug Design (2022) Vol. 101, Iss. 3, pp. 749-759
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top